prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, PATIENT HISTORY: Not provided. LMP: Not provided. PRE-OP DIAGNOSIS: Right breast cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Right breast segmental mastectomy, right axillary sentinel node biopsy. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. Antibody/Antigen. AE1/AE3 (1B). negative. Utilizing formalin-fixed (8-96 hour range) , paraffin embedded tissue, immunohistology is. performed with the following selected antibodies and designated antibody clone (s) directed. against the following antigenic target (s), with adequate positive and negative internal. and. external controls. Antibodies are optimized appropriate for fixation times. ANTIBODY. CLONE. TARGET ANTIGEN. VENDOR. AE1/AE3. AE1/AE3. carcinomas. The following statement applies to all immunohistochemistry, insitu hybridization (ISH & FISH), molecular anatomic pathology, and. immunofluorescence testing: The testing was developed and its performance characteristics determined by the I. 1, as. required by the CLIA '88 regulations. The testing has not been cleared or approved for the specific use by the U.S. Food and Drug. Administration, but the FDA has determined such approval Is not necessary for clinical use. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 ("CLIA") as qualified to perform high-. complexity clinical testing. Pursuant to the requirements of CLIA, ASR's used In this laboratory have been established and verified for. accuracy and precision. Additional information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.4 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Metaplastic carcinoma. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: Cribriform. Solid. DCIS admixed and outside of invasive carcinoma component. Percent of tumor occupied by in situ component: 5 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 2.0 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 4.0 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: SKIN INVOLVED (ULCERATION): T STAGE, PATHOLOGIC: pTic. N STAGE, PATHOLOGIC: pNO(i-). M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: negative. PROGESTERONE RECEPTORS: negative. HER2/NEU: zero or 1+. PATIENT HISTORY: Not provided. LMP: Not provided. PRE-OP DIAGNOSIS: Right breast cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Right breast segmental mastectomy, right axillary sentinel node biopsy. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT AXILLARY, SENTINEL #1, BIOPSY -. THREE (3) LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/3). PART 2: BREAST, RIGHT, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, METAPLASTIC TYPE. B. NEOPLASM MEASURES 1.4 CM ON SLIDE. C. NOTTINGHAM SCORE: 9/9, GRADE 3,. D. MARGINS OF RESECTION FREE OF NEOPLASM, CLOSEST POSTERIOR AT 0.2 CM. E. NO LYMPHOVASCULAR INVASION IDENTIFIED. F. ER NEGATIVE, PR NEGATIVE, HER-2/neu NEGATIVE (SCORE: 1+) PER PREVIOUS REPORT. G. PATHOLOGIC STAGE: pTic pNO pMX. H. DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES, NUCLEAR GRADE 3 WITH COMEDO. NECROSIS. I. DUCTAL CARCINOMA IN SITU IS ADMIXED AND ADJACENT TO INVASIVE COMPONENT. J. MARGINS OF RESECTION FREE OF DUCTAL CARCINOMA IN SITU, CLOSEST POSTERIOR AT 0.4 CM. K. UNREMARKABLE SKIN. L. MÖNCKEBERG'S CALCIFIC MEDIAL SCLEROSIS OF ARTERY. COMMENT: One of the lymph nodes is confirmed negative by Immunohistochemical staining (1B). The positive basal-like. Immunohistochemical markers performed on the previous blopsy combined with the presence of matrix production and. squamous differentiation in the current specimen support metaplastic subtype of Infiltrating ductal carcinoma.

expanded version (tokens=1591) : 
 Histological Classification:
- Type of Cancer: Infiltrating ductal carcinoma, metaplastic subtype
- Type of In Situ Cancer: Cribriform and solid DCIS, nuclear grade 3 with comedo necrosis

Subtype:
- Basal-like

Necrosis:
- Comedo necrosis is observed in the in situ component of the tumor.

Tumor Infiltrating Lymphocytes:
- No mention of tumor infiltrating lymphocytes in the report.

Histological Grade:
- Nottingham Score: Nuclear grade - 3, Tubule formation - 3, Mitotic activity score - 3
- Total Nottingham score - 9
- Nottingham grade - 3 (well-differentiated)

Nuclear grade:
- Nuclear grade of the invasive carcinoma is 3

Lymphovascular invasion:
- No lymphovascular invasion identified.

Calcification:
- Benign calcification present in the breast tissue.

Receptor Status:
- Estrogen receptors: negative
- Progesterone receptors: negative
- HER2/neu: negative (score: 1+)

IHC and Ancillary Testing Results:
- Immunohistochemistry performed with AE1/AE3 antibody showed negative results.
- Keratin stain used in the lymph node examination.
- No further ancillary testing results are mentioned in the report.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1736) : 
 Infiltrating ductal carcinoma, metaplastic subtype with basal-like features, nuclear grade 3 and Nottingham score of 9 was observed in a segmental mastectomy. Comedo necrosis and cribriform and solid DCIS with nuclear grade 3 were also noted. No lymphovascular invasion found. Receptor status showed ER-negative, PR-negative, and HER2/neu negative (score: 1+). Lymph nodes examined were negative for metastatic carcinoma.

